Delivery Order SPE2DB22D2006-SPE2DB25FV8EH
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,160.03, is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025 and uses a firm fixed price pricing type. This contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,393.18 firm fixed-price delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB22D2006|SPE2DB25FV7VU, is for the delivery of XIFAXAN 550 mg tablets, a medication used to treat certain gastrointestinal conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,073.50 and an ultimate completion date of January 27, 2025. This award...
This federal contract award is for the delivery order SPE2DB20D2200|SPE2DB24FW85S, which was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565099739 - XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a firm fixed price ceiling value of $1,777.98 and a completion date of July 10, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
This $157,381.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities to support...
This federal contract award, valued at $26,271.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. This is a delivery order contract with a firm fixed price, and the ultimate completion date is May 12, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of XIFAXAN 550 mg tablets. The firm-fixed-price contract, with a ceiling value of $22,755.48, is a delivery order award that covers an ultimate completion date of February 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $17,572.67 and runs through May 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FALQ9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,417.89 firm fixed-price delivery order is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XIFAXAN 550 mg tablets. The award, valued at $25,526.63, is a Firm Fixed Price delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. The contract does not have a set-aside designation and is intended to support the healthcare...